Phathom wins label expansion on heartburn drug to include non-erosive patients
Phathom Pharmaceuticals is digesting news of an expanded label for its heartburn drug Voquezna.
The FDA on Wednesday afternoon approved the drug for the relief …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
